Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA). (2019)

First Author: Reetz K
Attributed to:  Applying epigenetic modifying drugs to treat Friedreich's Ataxia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s42466-019-0038-9

PubMed Identifier: 33324899

Publication URI: http://europepmc.org/abstract/MED/33324899

Type: Journal Article/Review

Volume: 1

Parent Publication: Neurological research and practice

ISSN: 2524-3489